DSCR3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.150600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.362000E-01
Normal-vs-Stage2
2.643000E-01
Normal-vs-Stage3
4.286000E-02
Normal-vs-Stage4
3.117200E-01
Stage1-vs-Stage2
8.674200E-01
Stage1-vs-Stage3
1.628770E-01
Stage1-vs-Stage4
9.411000E-01
Stage2-vs-Stage3
1.146780E-01
Stage2-vs-Stage4
9.522800E-01
Stage3-vs-Stage4
1.839560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.812170E-01
Normal-vs-AfricanAmerican
8.351200E-01
Normal-vs-Asian
1.642810E-01
Caucasian-vs-AfricanAmerican
2.461900E-02
Caucasian-vs-Asian
3.776800E-01
AfricanAmerican-vs-Asian
5.578100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.310600E-01
Normal-vs-Female
1.942750E-01
Male-vs-Female
6.383800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.941800E-01
Normal-vs-Age(41-60Yrs)
5.124800E-01
Normal-vs-Age(61-80Yrs)
1.158390E-01
Normal-vs-Age(81-100Yrs)
1.839170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.996200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.861600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.998000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.902700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.696600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.692000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.446790E-01
Normal-vs-Daily Drinker
5.496000E-02
Normal-vs-Weekly Drinker
3.080000E-01
Normal-vs-Occasional Drinker
2.917200E-01
Normal-vs-Social Drinker
2.973200E-01
Non Drinker-vs-Daily Drinker
1.932770E-01
Non Drinker-vs-Weekly Drinker
8.171200E-01
Non Drinker-vs-Occasional Drinker
5.325400E-01
Non Drinker-vs-Social Drinker
7.420600E-01
Daily Drinker-vs-Weekly Drinker
2.406000E-01
Daily Drinker-vs-Occasional Drinker
9.480100E-02
Daily Drinker-vs-Social Drinker
1.919430E-01
Weekly Drinker-vs-Occasional Drinker
7.896000E-01
Weekly Drinker-vs-Social Drinker
9.481800E-01
Occasional Drinker-vs-Social Drinker
8.382400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.813380E-01
Normal-vs-Grade 2
1.274100E-02
Normal-vs-Grade 3
7.298300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.313600E-02
Grade 1-vs-Grade 3
1.129600E-02
Grade 1-vs-Grade 4
1.813380E-01
Grade 2-vs-Grade 3
2.605600E-01
Grade 2-vs-Grade 4
1.274100E-02
Grade 3-vs-Grade 4
7.298300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.062810E-01
Normal-vs-NonDiabetic
1.917010E-01
Diabetic-vs-NonDiabetic
3.067800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.776200E-01
Normal-vs-NoPancreatitis
1.575440E-01
Pancreatitis-vs-NoPancreatitis
1.165220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.785640E-01
Normal-vs-N1
2.516000E-01
N0-vs-N1
4.378600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.672400E-01
Normal-vs-TP53-NonMutant
3.542800E-01
TP53-Mutant-vs-TP53-NonMutant
4.400000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
